FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Andrei Purmal

Research Profile

Chemicals & Drugs

Anatomy

Erythrocytes

Procedures

Living Beings

Disorders

Concepts & Ideas

Phenomena

Gamma Rays

Co-author Network

Publications

TOP 3
Vadim I Krivokrysenko; Ratan K Maitra; Andrei Purmal; Alexander N Shakhov; Inna Shyshynova; Vijay K Singh; Mark H Whitnall; Frederick Bone; Alec Cheney; Andrei V Gudkov; Yevgeniy Kononov; Elena Feinstein
Identification of granulocyte colony-stimulating factor and interleukin-6 as candidate biomarkers of CBLB502 efficacy as a medical radiation countermeasure.
Vijay K Singh; Vera V Shakhova; Pankaj K Singh; Darren S Brown; Elizabeth J Ducey; Oluseyi O Fatanmi; Elena Feinstein; Andrei V Gudkov; Andrei Purmal; Alexander Shakhov
CBLB613: a TLR 2/6 agonist, natural lipopeptide of Mycoplasma arginini , as a novel radiation countermeasure.
Catherine A Burkhart; Fujiko Watt; Jayne Murray; Marina Pajic; Anatoly Prokvolit; Chengyuan Xue; Claudia Flemming; Janice Smith; Andrei Purmal; Nadezhda Isachenko; Pavel G Komarov; Katerina V Gurova; Alan C Sartorelli; Glenn M Marshall; Murray D Norris; Andrei V Gudkov; Michelle Haber
Small-molecule multidrug resistance-associated protein 1 inhibitor reversan increases the therapeutic index of chemotherapy in mouse models of neuroblastoma.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Andrei Purmal (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2012: Vadim I Krivokrysenko; Ratan K Maitra; Andrei Purmal; Alexander N Shakhov; Inna Shyshynova; Vijay K Singh; Mark H Whitnall; Frederick Bone; Alec Cheney; Andrei V Gudkov; Yevgeniy Kononov; Elena Feinstein
Identification of granulocyte colony-stimulating factor and interleukin-6 as candidate biomarkers of CBLB502 efficacy as a medical radiation countermeasure.
The Journal of pharmacology and experimental therapeutics 2012;343(2):497-508.
2012: Vijay K Singh; Vera V Shakhova; Pankaj K Singh; Darren S Brown; Elizabeth J Ducey; Oluseyi O Fatanmi; Elena Feinstein; Andrei V Gudkov; Andrei Purmal; Alexander Shakhov
CBLB613: a TLR 2/6 agonist, natural lipopeptide of Mycoplasma arginini , as a novel radiation countermeasure.
Radiation research 2012;177(5):628-42.
2009: Catherine A Burkhart; Fujiko Watt; Jayne Murray; Marina Pajic; Anatoly Prokvolit; Chengyuan Xue; Claudia Flemming; Janice Smith; Andrei Purmal; Nadezhda Isachenko; Pavel G Komarov; Katerina V Gurova; Alan C Sartorelli; Glenn M Marshall; Murray D Norris; Andrei V Gudkov; Michelle Haber
Small-molecule multidrug resistance-associated protein 1 inhibitor reversan increases the therapeutic index of chemotherapy in mouse models of neuroblastoma.
Cancer research 2009;69(16):6573-80.
2004: Boris Zavizion; Diana Serebryanik; John Chapman; Bernadette Alford; Andrei Purmal
Inactivation of Gram-negative and Gram-positive bacteria in red cell concentrates using INACTINE PEN110 chemistry.
Vox sanguinis 2004;87(3):143-9.
2004: Boris Zavizion; Mercio Pereira; Milena de Melo Jorge; Diana Serebryanik; Thomas N Mather; John Chapman; Nathan J Miller; Bernadette Alford; David J Bzik; Andrei Purmal
Inactivation of protozoan parasites in red blood cells using INACTINE PEN110 chemistry.
Transfusion 2004;44(5):731-8.
2004: Boris Zavizion; Andrei Purmal; John Chapman; Bernadette Alford
Inactivation of mycoplasma species in blood by INACTINE PEN110 process.
Transfusion 2004;44(2):286-93.
2004: Loren D Fast; John W Semple; Gilbert DiLeone; Michael Kim; John Freedman; John Chapman; Andrei Purmal
Inhibition of xenogeneic GVHD by PEN110 treatment of donor human PBMNCs.
Transfusion 2004;44(2):282-5.
2003: Boris Zavizion; Diana Serebryanik; Irina Serebryanik; John Chapman; Andrei Purmal
Prevention of Yersinia enterocolitica, Pseudomonas fluorescens, and Pseudomonas putida outgrowth in deliberately inoculated blood by a novel pathogen-reduction process.
Transfusion 2003;43(2):135-42.
2002: Aris Lazo; Jodie Tassello; Vasudevacharya Jayarama; Asa Ohagen; Veronica Gibaja; E Kramer; A Marmorato; D Billia-Shaveet; Andrei Purmal; F Brown; John Chapman
Broad-spectrum virus reduction in red cell concentrates using INACTINE PEN110 chemistry.
Vox sanguinis 2002;83(4):313-23.
2002: Loren D Fast; Gilbert DiLeone; Clark M Edson; Andrei Purmal
Inhibition of murine GVHD by PEN110 treatment.
Transfusion 2002;42(10):1326-32.
2002: Loren D Fast; Gilbert DiLeone; Clark M Edson; Andrei Purmal
PEN110 treatment functionally inactivates the PBMNCs present in RBC units: comparison to the effects of exposure to gamma irradiation.
Transfusion 2002;42(10):1318-25.
2002: James P AuBuchon; Constance A Pickard; Louise Herschel; Jill Roger; James E Tracy; Andrei Purmal; John Chapman; Samuel Ackerman; Kathleen J Beach
Production of pathogen-inactivated RBC concentrates using PEN110 chemistry: a Phase I clinical study.
Transfusion 2002;42(2):146-52.
2002: Andrei Purmal; C Robert Valeri; Walter Dzik; Linda E Pivacek; Gina Ragno; Aris Lazo; John Chapman
Process for the preparation of pathogen-inactivated RBC concentrates by using PEN110 chemistry: preclinical studies.
Transfusion 2002;42(2):139-45.